Log in

Relevant bibliographies by topics / 65.012.34 (043.2)

Contents

Journal articles

Academic literature on the topic '65.012.34 (043.2)'

Author: Grafiati

Published: 30 May 2022

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic '65.012.34 (043.2).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "65.012.34 (043.2)"

1

Rogers, Jonathan, Camarie Welgemoed, and Dorothy Gujral. "Does body mass index or subcutaneous adipose tissue thickness affect interfraction prostate motion in patients receiving radical prostate radiotherapy?" Journal of Radiotherapy in Practice 15, no. 4 (2016): 334–40. http://dx.doi.org/10.1017/s1460396916000364.

Full text

Abstract:

AbstractAimIt is unclear whether body mass index (BMI) is a useful measurement for examining prostate motion. Patient’s subcutaneous adipose tissue thickness (SAT) and weight has been shown to correlate with prostate shifts in the left/right direction. We sought to analyse the relationship between BMI and interfraction prostate movement in order to determine planning target volume (PTV) margins based on patient BMI.Materials and methodsIn all, 38 prostate cancer patients with three implanted gold fiducial markers in their prostate were recruited. Height, mass and SAT were measured, and the ext

APA, Harvard, Vancouver, ISO, and other styles

2

Kantarjian, Hagop M., Alfonso Quintas-Cardama, Susan O’Brien, et al. "Importance of Early Intervention with Dasatinib at Cytogenetic Rather Than Hematologic Resistance to Imatinib." Blood 110, no. 11 (2007): 1036. http://dx.doi.org/10.1182/blood.v110.11.1036.1036.

Full text

Abstract:

Abstract Recent data for patients with chronic-phase (CP) CML indicate that development of resistance or intolerance to imatinib and treatment intervention following progression to advanced-phase disease are both associated with poor clinical outcome (with 3-year survival rates of 72% for chronic-phase disease, 30% for accelerated-phase CML, and 7% for blast-phase CML) (Kantarjian et al. Cancer2007;109:1556–60). Results also demonstrate that intervention with a second-generation tyrosine kinase inhibitor is more effective for individuals with chronic-phase CML than for those with advanced-phas

APA, Harvard, Vancouver, ISO, and other styles

3

Sonneveld, Pieter, Ingo G. H. Schmidt-Wolf, Bronno van der Holt, et al. "Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial." Journal of Clinical Oncology 30, no. 24 (2012): 2946–55. http://dx.doi.org/10.1200/jco.2011.39.6820.

Full text

Abstract:

Purpose We investigated whether bortezomib during induction and maintenance improves survival in newly diagnosed multiple myeloma (MM). Patients and Methods In all, 827 eligible patients with newly diagnosed symptomatic MM were randomly assigned to receive induction therapy with vincristine, doxorubicin, and dexamethasone (VAD) or bortezomib, doxorubicin, and dexamethasone (PAD) followed by high-dose melphalan and autologous stem-cell transplantation. Maintenance consisted of thalidomide 50 mg (VAD) once per day or bortezomib 1.3 mg/m2 (PAD) once every 2 weeks for 2 years. The primary analysis

APA, Harvard, Vancouver, ISO, and other styles

4

Дидоренко, Светлана, Эльмира Кисетова, Ринат Касенов, Жасулан Байжанов, Рыстай Кушанова та Исламбек Сагит. "ПРОДУКТИВНОСТЬ И КАЧЕСТВО СОРТОВ СОИ СОЗДАННЫХ НА РАЗНЫХ ЭТАПАХ СЕЛЕКЦИОННЫХ РАБОТ В КАЗАХСКОМ НАУЧНО – ИССЛЕДОВАТЕЛЬСКОМ ИНСТИТУТЕ ЗЕМЛЕДЕЛИЯ И РАСТЕНИЕВОДСТВА". Izdenister natigeler, № 2-1 (special) (29 червня 2024): 85–98. http://dx.doi.org/10.37884/2-1-2024/542.

Full text

Abstract:

В 2021 году площадь посевов сои в Республике Казахстан составила 113,3 тыс. га, а в 2022 году - 128,0 тыс. га с валовым сбором зерна - 250,4 тыс. тонн. В последние годы в посевах сои в стране доля отечественных сортов составляла от 55 до 65 %. Лидером по величине посевных площадей сои является Алматинская область, где сосредоточено 83,6 % посевов (94,7 тысяч гектар); далее следует Костанайская – 7,7 % (8,8 тыс. га); Восточно-Казахстанская – 5 % (5,6 тыс. га); Северо-Казахстанская – 2,8 % (3,2 тыс. га); Туркестанская – 0,1 % (0,2-0,3 тыс. га); и другие области. За годы селекционной работы в Каз

APA, Harvard, Vancouver, ISO, and other styles

5

Collette, Christopher, Amani M. Norling, Randall A. Walden, et al. "30 Hippocampal Internal Architecture Subfield Volumes Associated with Systematic Inflammatory Biomarkers in Multiple Sclerosis." Journal of the International Neuropsychological Society 29, s1 (2023): 546–47. http://dx.doi.org/10.1017/s1355617723007014.

Full text

Abstract:

Objective:Multiple Sclerosis (MS) affects up to 500,000 adults in the United States, with cognitive impairment present in 45%-65% of people. Studies showed hippocampal atrophy in MS, but the underlying mechanisms remain unknown. Inflammation has been proposed to play a significant role, and associations between systemic inflammatory biomarkers and hippocampal atrophy have been shown in other neurological conditions. However, research exploring serum biomarker and volumetric associations in MS are lacking. Given that conventional imaging methods lack resolution for hippocampal internal architec

APA, Harvard, Vancouver, ISO, and other styles

6

ศรีโกไสย, สุนทรี, อุไรวรรณ วงศ์โปธิ, ณัฏฐ์พิมล วงศ์เมือง та อนงค์พร ต๊ะคำ. "การพัฒนาระบบบริการสุขภาพจิตผู้ปกครองของเด็กและวัยรุ่นที่มีปัญหาสุขภาพจิตและพัฒนาการ". Journal of Thailand Nursing and Midwifery Council 38, № 02 (2023): 88–104. http://dx.doi.org/10.60099/jtnmc.v38i02.261791.

Full text

Abstract:

บทนำ ที่ผ่านมายังไม่มีระบบที่ชัดเจนในการบริการสุขภาพจิตผู้ปกครอง และการคัดกรองยังไม่ครอบคลุม มีข้อจำกัดในการเข้าถึงบริการของผู้ปกครองที่มีปัญหาสุขภาพจิต รวมทั้งความเชื่อมโยงระหว่างหน่วยบริการ วัตถุประสงค์การวิจัย เพื่อพัฒนาระบบบริการสุขภาพจิตผู้ปกครองของเด็กและวัยรุ่นที่มีปัญหาสุขภาพจิต และพัฒนาการ ทดสอบประสิทธิภาพและประสิทธิผลของโปรแกรมการบำบัดสังคมจิตใจแบบสั้นแนวซาเทียร์โมเดล การออกแบบวิจัย การวิจัยและพัฒนา วิธีดำเนินการวิจัย การวิจัยแบ่งเป็น 5 ระยะ ทำการศึกษาระหว่าง มกราคม 2563 - ธันวาคม 2565 ระยะที่ 1 วิเคราะห์ ความต้องการความจำเป็น ระยะที่ 2 ออกแบบระบบบริการสุขภาพจิตผู้ปกครอง ระยะที่ 3 สร

APA, Harvard, Vancouver, ISO, and other styles

7

Nurse, Daniel P., Wei Wei, Amanda Burns, et al. "Assessment of Secondary Malignancies after Allogeneic Hematopoietic Cell Transplant When Comparing Treatment with and without Post-Transplant Cyclophosphamide." Blood 144, Supplement 1 (2024): 7383. https://doi.org/10.1182/blood-2024-202626.

Full text

Abstract:

Introduction Secondary malignancies (SM) may occur as a late toxicity after allogeneic hematopoietic cell transplant (alloHCT) and result in significant morbidity and mortality. It is currently unknown what effect the use of post-transplant cyclophosphamide (PTCy) may have on the development of SM. The primary objective of this study was to compare the incidence of SM after alloHCT between patients treated with and without PTCy. Methods We conducted a single-center retrospective cohort study of 1,124 patients who underwent alloHCT from 2011 to 2021. Time to the development of SM (ttSM) was cal

APA, Harvard, Vancouver, ISO, and other styles

8

Ortiz, Johana, John Van Camp, Sylviana Wijaya, Silvana Donoso, and Lieven Huybregts. "Determinants of child malnutrition in rural and urban Ecuadorian highlands." Public Health Nutrition 17, no. 9 (2013): 2122–30. http://dx.doi.org/10.1017/s1368980013002528.

Full text

Abstract:

AbstractObjectiveTo identify and compare the sociodemographic determinants of stunting, wasting and overweight among infants of urban and rural areas in the Ecuadorian highlands.DesignCross-sectional study.SettingNabon (rural) and Cuenca (urban) cantons, Azuay Province, Ecuador.SubjectsA total of 703 children aged 0–24 months and their caregivers (227 rural and 476 urban) recruited during the period from June to September 2008.ResultsStunting prevalence was significantly higher in the rural area (37·4 %v. 17·7 %;P< 0·001) while wasting (7·1 %) and overweight (17·1 %) prevalence were more si

APA, Harvard, Vancouver, ISO, and other styles

9

Palumbo, Antonio, Meletios A. Dimopoulos, Katja Weisel, et al. "Outcomes for Older Patients in Stratus (MM-010), a Single-Arm, and Phase 3b Study of Pomalidomide + Low-Dose Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma." Blood 124, no. 21 (2014): 4770. http://dx.doi.org/10.1182/blood.v124.21.4770.4770.

Full text

Abstract:

Abstract Background: Survival of patients (pts) with multiple myeloma (MM) decreases with increased age (Pulte, Oncologist, 2011). In addition, MM pts with advanced disease who have exhausted treatment (Tx) with novel agents have a poor prognosis (Kumar, Leukemia, 2012). Pomalidomide (POM) is a new oral agent with antimyeloma, stromal cell inhibitory, and immune modulatory effects (Quach, Leukemia, 2010; Mark, Leuk Res, 2014). In the pivotal MM-003 trial, POM in combination with low-dose dexamethasone (LoDEX) demonstrated significant progression-free survival (PFS) and overall survival (OS) be

APA, Harvard, Vancouver, ISO, and other styles

10

Kunte, Siddharth Jayant, Lisa Rybicki, Auro Viswabandya, et al. "Haploidentical Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in Patients with Myelofibrosis: A Multi-Institutional Experience." Blood 136, Supplement 1 (2020): 33–34. http://dx.doi.org/10.1182/blood-2020-136622.

Full text

Abstract:

Background: Primary and secondary [post-essential thrombocythemia (ET) or polycythemia vera (PV)] Myelofibrosis (MF) are clonal hematopoietic neoplasms marked by constitutive JAK-STAT activation, bone marrow fibrosis, cytopenias, and constitutional symptom burden. Allogeneic hematopoietic cell transplantation (HCT) is the only curative option in this disease. Median overall survival (OS) after JAK inhibitor (JAKi) discontinuation is poor, ranging from 6-24 months (Harrision et al. Ann Hematol. 2020). Haploidentical (Haplo)-HCT with post-transplant cyclophosphamide (PTCy) has improved donor ava

APA, Harvard, Vancouver, ISO, and other styles

More sources

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!